For those considering using medical marijuana that are already on other prescriptions medications, this is a huge concern.
So, I’m going to do a deep-dive into this topic with you – by starting with the basics.
What is Cytochrome (CYP) P450?
When we’re talking about any adverse drug-to-drug interactions, one of the key players is Cytochrome P450. It’s like a demolition company in our bodies. It’s just is to take drugs part. And, it’s responsible for breaking down 60% of prescription drugs that enter our bodies.
CYP can be made to work quicker or slower by other drugs, foods, or substances that you consume.
Let me walk you through a couple examples.
Let’s take grapefruit juice. Grapefruit juice is an inhibitor of Cytochrome P450. In other words, it slows Cytochrome P450 down. So, say you downed some medication with some grapefruit juice, it’s likely that Cytochrome P450 will work as slow as molasses in breaking down that medication. So, grapefruit juice puts CYP in vacation mode.
Now, let’s take tobacco. Tobacco is a Cytochrome P450 inducer. In other words, it makes Cytochrome P450 work really, really fast. So if you had some medication and then decided to go out for a smoke, it’s likely that Cytochrome P450 will have that medication broken down in no time. So, tobacco makes Cytochrome P450 hyperproductive.
When Cytochrome P450 works too slowly or too quickly, it’s no bueno. It can cause problems. The levels of the medication you take could become toxic or, the opposite, they become completely ineffective.
So, now that you know the basics about Cytochrome P450, I want to move on to talk about how marijuana affects Cytochrome P450. I’m going to focus on the 2 cannabinoids that marijuana makes in the greatest abundance. And, those are Cannabidiol (CBD) and Tetrahydrocannabinol (THC).
THE RESEARCH IN ANIMAL MODELS AND TEST TUBES
Research in animal models and in test tubes has shown that both CBD and THC slow Cytochrome P450 down. Between CBD and THC, CBD was found to have a greater impact on slowing down CYP than THC. Specifically, the way in which CBD slows down CYP is that it blocks the breakdown of prescription medications. Researchers did find that it typically took really high concentrations of CBD to actually slow down Cytochrome P450.
RESEARCH IN HUMANS
So, there has been some research done on this topic in humans as well. They’ve been studies done using some very
specific prescribed medications.
Cannabidiol (CBD) and CLOBAZAM
One study looked at the effects of CBD on an anti-seizure medication called Clobazam. They looked to see what happened when 13 kids with Epilepsy were given Clobazam with CBD. They basically found that CBD led to less break-down of Clobazam. Basically, it stuck around longer than normal. And, as a result, the doses of Clobazam that these kids were on had to be reduced. And, in turn, the kids experienced fewer side effects of the Clobazam.
Cannabidiol (CBD) and HEXOBARBITAL
Another study looked at the effects of CBD on a medication called Hexobarbital. It’s a medication that was used back in the 1940’s and 1950’s as anesthesia, but isn’t really used anymore. The results of the study showed that, again, CBD led to less of break-down of Hexobarbital. So, basically it also stuck around longer.
And, you’re probably wondering, what does this mean for me, the patient that’s using medical marijuana?
In theory, taking medical marijuana with your prescription medications should impact the breakdown of the prescription medications that you’re taking, but, in general, clinically, this hasn’t really been the case.
So, there’s been a decent amount of research done using marijuana. And, a lot of the participants continued to take their prescription medications while participating in the study. So, basically, they were using marijuana along with their prescription medications for conditions like,
Overall, the participants of these studies didn’t report any adverse drug-to-drug interactions nor did the researchers observe any adverse drug-to-drug interactions.
Marijuana and Interactions with Other Medications: IN PRACTICE
I’ve been treating patients with medical marijuana since 2012, and in that time I haven’t had any patients report any adverse drug-to-drug interactions either nor have I observed any general trends with adverse drug-to-drug interactions.
Of course, we need more information by way of research, but so far this is what we know and what I’ve seen in my medical marijuana practice.
So there you have it – everything you wanted to know about using medical marijuana and interactions with your prescriptions medications.
As always, I hope you found this informative.
Now that you know that in general it is possible to safely take your medications with medical marijuana, would you like my help? Head on over to the GET HELP page. I’ll step-by-step walk you through how to safely use medical marijuana with your current prescription and over-the-counter medications.
- Drug interactions due to cytochrome P450.
- The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
- Grapefruit juice-drug interactions.
- Characterization of Cytochrome P450 3A Inactivation by Cannabidiol: Possible Involvement of Cannabidiol-Hydroxyquinone as a P450 Inactivator
- Siemens, A. J., Kalant, H., Khanna, J. M., Marshman, J., and Ho, G. (1974) Effect of cannabis on pentobarbital-induced sleeping time and pentobarbital metabolism in the rat. Biochem. Pharmacol. 23, 477-488.
- Bornheim, L. M., Borys, H. K., and Karler, R. (1981) Effect of cannabidiol on cytochrome P-450 and hexobarbital sleep time. Biochem. Pharmacol. 30, 503-507.
- Hamajima, K., Watanabe, K., Narimatsu, S., Tateoka, Y., Yamamoto, I., and Yoshimura, H. (1983) Sex difference in the effects of ∆9-tetrahydrocannabinol and cannabidiol on pentobarbital induced sleeping time and hepatic microsomal drug metabolizing enzyme systems in mice. Yakugaku Zasshi 103, 1289-1297.
- Watanabe, K., Arai, M., Narimatsu, S., Yamamoto, I., and Yoshimura, H. (1987) Self-catalyzed inactivation of cytochrome P-450 during microsomal metabolism of cannabidiol. Biochem. Pharmacol. 36, 3371-3377.
- Bornheim, L. M., and Correia, M. A. (1989) Effect of cannabidiol on cytochrome P-450 isozymes. Biochem. Pharmacol. 38, 2789- 2794.
- Bornheim, L. M. (1989) Effect of cannabidiol on drug metabolism. In Biochemistry and Physiology of Substance Abuse (Watson, R., Ed.) Vol. 1, pp 21-35, CRC Press, Boca Raton, FL
- Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety
- Fernandes M, Warning N, Christ W, Hill R. Interactions of several cannabinoids with the hepatic drug metabolizing system. Biochem Pharmacol 1973;22:2981–7.
- Chan MY, Tse A. The effect of cannabinoids (Δ9 -THC and Δ8 -THC) on hepatic microsomal metabolism of testosterone in vitro. Biochem Pharmacol 1978;27:1725–8.
- Geffrey, A. L., Pollack, S. F., Bruno, P. L., & Thiele, E. A. (2015): Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy. Epilepsia, 56(8), 1246-1251.
- Benowitz, N. L., Nguyen, T. L., Jones, R. T., Herning, R. I., & Bachman, J. (1980): Metabolic and psychophysiologic studies of cannabidiol-hexobarbital interaction. Clinical Pharmacology & Therapeutics, 28(1), 115-120.
- A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers.
- Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol.
- Aggarwal SK. Cannabinergic pain medicine: a concise clinical primer and survey of randomized-controlled trial results. Clin J Pain. 2013;29(2):162-71.